125 related articles for article (PubMed ID: 6357933)
1. Immune-enhancing effect of recombinant human interferon-beta produced in Escherichia coli on human peripheral blood mononuclear cells in vitro.
Okabe M; Morimoto M; Nakamizo N
Gan; 1983 Oct; 74(5):743-50. PubMed ID: 6357933
[TBL] [Abstract][Full Text] [Related]
2. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
Okabe M; Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
[TBL] [Abstract][Full Text] [Related]
3. Growth-inhibitory activity of recombinant human interferon-beta against cultured human cells.
Gomi K; Morimoto M; Nakamizo N
Gan; 1983 Oct; 74(5):737-42. PubMed ID: 6642144
[TBL] [Abstract][Full Text] [Related]
4. Different kinetics of antiviral and anticellular activities between human recombinant and natural interferon-gamma arising from different receptor-binding properties.
Gomi K; Akinaga S; Inoue A; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1986 Sep; 77(9):946-55. PubMed ID: 3095289
[TBL] [Abstract][Full Text] [Related]
5. Effect of interferon on antibody-dependent cellular cytotoxicity (ADCC) in chickens.
Mándi Y; Bakay M; Béládi I
Acta Microbiol Hung; 1984; 31(2):127-33. PubMed ID: 6464658
[TBL] [Abstract][Full Text] [Related]
6. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
7. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of antiviral and anticellular activities of human recombinant interferon-gamma.
Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Mar; 76(3):224-34. PubMed ID: 3922841
[TBL] [Abstract][Full Text] [Related]
9. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
Mandler RN; Biddison WE; Mandler R; Serrate SA
J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
11. [Effect of human recombinant beta-interferon on natural killer activity of peripheral lymphocytes in cancer patients].
Beika T; Tanaka N; Yamada J; Hizuta A; Onishi K; Akura Y; Hirose K; Orita K
Gan To Kagaku Ryoho; 1985 Feb; 12(2):362-5. PubMed ID: 3970557
[TBL] [Abstract][Full Text] [Related]
12. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
Platsoucas CD
Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of human recombinant interferon-beta in monkeys and rabbits.
Gomi K; Morimoto M; Inoue A; Kobayashi H; Deguchi T; Hara T; Nakamizo N
Gan; 1984 Mar; 75(3):292-300. PubMed ID: 6724230
[TBL] [Abstract][Full Text] [Related]
14. Interferon enhances antibody-dependent cellular cytotoxicity when suboptimal concentrations of antibody are used.
Basham TY; Smith WK; Merigan TC
Cell Immunol; 1984 Oct; 88(2):393-400. PubMed ID: 6435886
[TBL] [Abstract][Full Text] [Related]
15. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
Gomi K; Akinaga S; Oka T; Morimoto M
Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell function in trisomy-21 (Down's syndrome).
Nurmi T; Huttunen K; Lassila O; Henttonen M; Säkkinen A; Linna SL; Tiilikainen A
Clin Exp Immunol; 1982 Mar; 47(3):735-41. PubMed ID: 6177458
[TBL] [Abstract][Full Text] [Related]
17. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
18. The effect of interferon on ADCC (I).
Spangsbjerg N; Heron I
Acta Pathol Microbiol Immunol Scand C; 1983 Oct; 91(5):315-21. PubMed ID: 6659937
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
20. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
Jewett A; Giorgi JV; Bonavida B
J Immunol; 1990 Dec; 145(12):4065-71. PubMed ID: 2258607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]